Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.3%

2 terminated/withdrawn out of 61 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

7%

1 of 14 completed trials have results

Key Signals

12 recruiting1 with results

Enrollment Performance

Analytics

N/A
26(70.3%)
Phase 2
5(13.5%)
Phase 1
4(10.8%)
Phase 3
1(2.7%)
Early Phase 1
1(2.7%)
37Total
N/A(26)
Phase 2(5)
Phase 1(4)
Phase 3(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (61)

Showing 20 of 61 trials
NCT03133650Phase 1Active Not Recruiting

A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing

Role: collaborator

NCT07081087Recruiting

Replacing Bone Marrow Diagnostics With Peripheral Blood Analysis in Cytopenia Patients

Role: lead

NCT04283864Active Not Recruiting

Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease

Role: lead

NCT04633369Not ApplicableActive Not Recruiting

The Role of the Microbiome in the Response to Dietary Fibers Intake During Intermediate Fasting

Role: lead

NCT03627923Active Not Recruiting

Personalizing Mediterranean Diet in Children.

Role: lead

NCT06681246Not ApplicableRecruiting

The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment

Role: lead

NCT03334708Recruiting

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

Role: collaborator

NCT04813653Phase 1Completed

Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells

Role: collaborator

NCT05972317Not ApplicableRecruiting

The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients

Role: lead

NCT06494826Recruiting

Decoding the Clinical Impact of Host and Microbial Intestinal Proteomic Landscape in Crohn's Disease

Role: lead

NCT06968312Not ApplicableRecruiting

Hexadecanal as an Addon to Cognitive Processing Therapy for PTSD

Role: collaborator

NCT05325736Recruiting

Improvement in Glycemic Response After Bariatric Surgery

Role: lead

NCT04517487Not ApplicableRecruiting

Vaginal Microbiome Transplantation for Recurrent Bacterial Vaginosis

Role: collaborator

NCT03558867Not ApplicableCompleted

Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes

Role: collaborator

NCT05817734Recruiting

Human Phenotype Project Study Protocol

Role: lead

NCT04823364Not ApplicableTerminated

Evaluation of Brain Neurotransmitter Levels in Adults With ADHD, Before and After Stimulant Treatment

Role: lead

NCT05329636Phase 1Recruiting

Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy

Role: collaborator

NCT06377306Recruiting

Identifying Periods of High Training Load Considering the Menstrual Cycle Phases in Elite and Non-elite Female Athletes

Role: collaborator

NCT03872622Not ApplicableCompleted

Intestinal Response Patterns to Microbial Signals

Role: collaborator

NCT04840823Phase 1Completed

Enoxacin for Amyotrophic Lateral Sclerosis (ALS)

Role: collaborator